| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |